Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Analytical QbD: Designing Space for HPLC Method Operable Region for Estimation of Preservatives in Herbal Formulation

Author(s): Kalpana Patel, Hinal Jitendrabhai Patel, Jenee Christian*, Lal Hingorani and Tejal Gandhi

Volume 15, Issue 2, 2019

Page: [152 - 164] Pages: 13

DOI: 10.2174/1573412914666171218151224

Price: $65

Abstract

Background: Quantification of preservatives in herbal formulation, simultaneously by high performance liquid chromatography analysis is very complex and involves series of steps including sample preparation, selection of suitable mobile phase and its validation for routine applications.

Introduction: Application of Quality by Design (QbD) in the development of novel, simple, accurate and precise RP-HPLC method for concurrent quantification of quaternary preservatives in herbal formulation, focusses on development of robust method.

Methods: Isocratic analysis was carried out using C18 column at 231 nm. Risk assessment studies were executed to determine the critical method parameters which were defined as acetonitrile volume in the mobile phase, volume of injection and orthophosphoric acid concentration in the mobile phase. The effect of the critical method parameters on critical method attributes, i.e. retention time, resolution and chromatographic optimization function was further evaluated by means of central composite design and the optimal conditions were determined through derringer’s desirability approach of multi-criteria decision making technique.

Results: The method was statistically validated according to ICH guidelines having good resolution using optimized mobile phase, acetonitrile: 0.11% orthophosphoric acid in water (12.30: 87.70 % v/v) giving acceptable retention time i.e. 3.7128 ± 0.0138 of bronopol, 4.5106 ± 0.00542 of sodium propyl paraben, 10.7228 ± 0.029 of sodium benzoate and 12.252 ± 0.027 of sodium methyl paraben.

Conclusion: Hence, the QbD based method development assisted in generating a design space with knowledge of all method performance characteristics leading to a better understanding of the method, and achieving desirable method quality.

Keywords: CCD, HPLC, herbal, preservative, risk, validation.

« Previous Next »
Graphical Abstract

[1]
Hulikal, P.; Kumar, P.; Ramachandran, S.; Ramakrishnan, S. Design and development of self-preserving and preservative-free herbal liquid oral formulation. J. Appl. Pharm. Sci., 2015, 5(1), 54-60.
[2]
Agarwal, K. Proceedings of World Ayurveda Congress, Cochin2002.
[3]
Shrikumar, S.; Ravi, K. Approaches towards development and promotion of herbal drugs. Pharm. Rev., 2007, 1(1), 180-184.
[4]
Vogt, G.; Kord, S. Development of quality- by-design analytical methods. J. Pharm. Sci., 2011, 100(3), 797-812.
[5]
ICH Guideline Q8(R2), Pharmaceutical development: Text and methodology, 2005.
[6]
Reid, L.; Morgado, J.; Barnett, K.; Harrington, B.; Wang, J.; Harwood, J.; Fortin, D. Analytical quality by design (AQbD) in pharmaceutical development. Am. Pharmaceut. Rev., 2013, 144-191.
[7]
Bhutani, H.; Kurmi, M.; Singh, S.; Beg, S.; Singh, B. Quality by design (QbD) in analytical sciences: An overview. Pharm. Times, 2014, 46, 71-75.
[8]
Krishna, M.; Dash, N.; Reddy, B.; Venugopal, P.; Sandeep, P.; Madhavi, G. Quality by Design (QbD) approach to develop HPLC method for eberconazole nitrate: Application to hydrolytic, thermal, oxidative and photolytic degradation kinetics. J. Saudi Chem. Soc., 2013, 20, S313-S322.
[9]
Indian Pharmacopoeia, Ministry of Health & Family Welfare, Ghaziabad: Indian Pharmacopeial commission 2014; 7th Ed: 177, 191, 199, 2204, 2738.
[10]
Indian Pharmacopoeia, Ministry of Health & Family Welfare, Ghaziabad: Indian Pharmacopeial commission 2014; 6th Ed: 70, 599, 627.
[11]
The United States Pharmacopoeia 35- National Formulary 30, The United States Pharmacopoeial Convention 2012: 260-265, 1868, 1938, 1950.
[12]
British Pharmacopoeia, Council of Europe 2009:794, 3853, 5434, 5537
[13]
Grosa, G.; Grosso, D.; Russo, R.; Allegrone, G. Simultaneous, stability indicating, HPLC -DAD determination of guaifenesin and methyl and propyl-parabens in cough syrup. J. Pharm. Biomed. Anal., 2006, 41, 798-803.
[14]
Andre, D.; Ronald, E.; Barbas, C.; Javier, R. Separation of Paraben Preservatives by Reversed - Phase HPLC, application in Foods, beverages & Cosmetics; Agilent Tech. Inc, 2005, pp. 1-4.
[15]
Marten, S. Determination of preservatives in foodstuffs and cosmetics VFD3., 2007.www.knauer.net
[16]
Kumar, S.; Mathkar, S.; Romero, C.; Rustum, M. Development and validation of a single RP-HPLC assay method for analysis of bulk raw material batches of four parabens that are widely used as preservatives in pharmaceutical and cosmetic products. J. Chromatogr. Sci., 2011, 49, 405-411.
[17]
Subert, J.; Farsa, O.; Mareckova, M. Stability evaluation of methylparaben and propylparaben in their solution aqua conservans using HPLC. Sci. Pharm., 2007, 75, 171-177.
[18]
Fitzpatrick, A.; Summa, F.; Coopert, D. Quantitative analysis of methyl and propyl paraben by high performance liquid chromatography. J. Soc. Cosmet. Chem., 1975, 26, 377-387.
[19]
Chu, Y.; Chen, L.; Wang, F. A rapid method for the simultaneous determination of preservatives in soy sauce. J. Food Drug Anal., 2003, 11(3), 246-250.
[20]
Turabi, M.; Khatatbeh, A.; Dalal, A.N. RP-HPLC method development and validation for the simultaneous determination of mebendazole and the two preservatives methylparaben and propylparaben in pharmaceutical oral suspension dosage form. Int. J. Pharm. Sci. Drug Res., 2014, 6(1), 70-74.
[21]
Saada, B.; Baria, F.; Saleh, I.; Kamarudzaman, A.; Talib, K. Simultaneous determination of preservatives (benzoic acid, sorbic acid, methylparaben and propylparaben) in foodstuff high-performance liquid chromatography. J. Chromatogr. A, 2005, 1073, 393-397.
[22]
Koscinski, B.; McLeroy, G.; Jess, R.; Pixley, C.; Sparling, P. determination of benzoic acid, sorbic acid, and methyl, ethyl, propyl, and butyl parabens by HPLC. US Dep. Agri. Food Safety & Ins. Ser. Office Public Health Sci, 2004, 766, 1-15.
[23]
Kumar, N.; Dhanaraj, S.; Reddy, S.; Lakkireddy, P. A validated stability indicating rp-uplc method for simultaneous determination of water soluble vitamins, caffeine and preservatives in pharmaceutical formulations. Sci. Pharm., 2012, 80, 153-165.
[24]
Shabir, A. a new validated hplc method for the simultaneous determination of 2-phenoxyethanol, methylparaben, ethylparaben and propylparaben in a pharmaceutical gel. Indian J. Pharm. Sci., 2010, 72(4), 421-425.
[25]
Wankhede, B.; Chitlange, S. A novel HPTLC method for simultaneous determination of alprazolam and methyl paraben in tablet dosage form. Sch. Res. Lib, 2013, 5(1), 89-93.
[26]
Dhahir, A.; Hussein, J. Spectrophotometric determination of methyl paraben in pure and pharmaceutical oral solution. Adv. Nat. Sci., 2013, 6(4), 69-74.
[27]
Paul, S.; Chandrul, K.; Bhadu, R. A validated rp- hplc method for simultaneous estimation of bronopol in lactulose solution USP. J. Chem. Pharm. Res., 2011, 3(3), 563-571.
[28]
Borisova, L.; Jonsson, S.; Fransson, D.; Tammela, M.; Johansson, M. Screening procedure for determination of preservatives in commercial skin-care products. Lakemedelsverket Med. Pro. Age., 2011, 1-23.
[29]
Baranowska, I.; Wojciechowska, I. The Determination of preservatives in cosmetics and environmental water by HPLC. Pol. J. Environ. Stud., 2013, 22(6), 1609-1625.
[30]
Boukarim, C.; Jaoude, A.; Bahnam, R.; Barada, R.; Kyriacos, S. Preservatives in liquid pharmaceuticals preparations. J. Appl. Res., 2009, 9(1-2), 14-17.
[31]
Abdollahpoura, A.; Forouhib, M.; Shamsipurc, M.; Yaminia, Y. High performance liquid chromatographic determination of sodium benzoate, methylparaben and propylparaben as preservative components in nystatin suspensions. J. Iran Chem. Soc, 2010, 7(2), 516-520.
[32]
Hasan, N.; Chaiharn, M. Shah. N.; Khalid, H.; Jabbar, A. Simultaneous determination of NSAID and antimicrobial preservatives using validated RP-HPLC method: An application in pharmaceutical and clinical laboratories. Pharm. Anal. Acta, 2013, 4(8), 1-7.
[33]
Kuprovskyte, K.; Pranaityte, B.; Padarauskas, A. Isocratic HPLC determination of preservatives in bevarages. ISSN Chem, 2002, 13(3), 160-163.
[34]
Pylypiw, M.; Grether, T. Rapid high-performance liquid chromatography method for the analysis of sodium benzoate and potassium sorbate in foods. J. Chromatogr. A, 2000, 883, 299-304.
[35]
Khosrokhavar, R.; Sadeghzadeh, N.; Amini, M.; Ghazi-Khansari, M.; Hajiaghaee, R.; Mehr, E. Simultaneous determination of preservatives (sodium benzoate and potassium sorbate) in soft drinks and herbal extracts using High-Performance Liquid Chromatography (HPLC). J. Med. Plants., 2010, 9(35), 80-87.
[36]
Kucukcetin, A.; Bulent, S.; Demir, M. Determination of sodium benzoate, potassium sorbate, nitrate and nitrite in some commercial dairy products. Res. Arti, 2008, 33(4), 159-164.
[37]
Bahremand, N.; Eskandari, S. Determination of potassium sorbate and sodium benzoate in doogh by hplc and comparison with spectrophotometry. Int. J. Bio., 2013, 2(3), 429-435.
[38]
Kumar, N.; Dhanaraj, S.; Reddy, S.; Lakkireddy, P. A validated stability-indicating rp-uplc method for simultaneous determination of desloratadine and sodium benzoate in oral liquid pharmaceutical formulations. Sci. Pharm., 2012, 80, 153-165.
[39]
Galli, V.; Barbas, C. High-performance liquid chromatographic analysis of dextromethorphan, guaifenesin and benzoate in a cough syrup for stability testing. J. Chromatogr. A, 2004, 1048, 207-211.
[40]
Wilson, D.; Jump, G. Validation of improved methods for high-performance liquid chromatograpic determination of phenylpropanolamine, dextromethorphan, guaifenesin and sodium benzoate in a cough-cold formulation. J. Chromatogr. A, 1993, 641, 241-248.
[41]
Monks, K.; Molnar, I.; Rieger, J.; Bogati, B.; Szabo, E. Quality by design: Multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation. J. Chromatogr. A, 2012, 1232, 218-230.
[42]
Nethercote, P.; Ermer, J. Quality by design for analytical methods: Implications for method validation and transfer; Pharma. Tech, 2012, pp. 1-10.
[43]
Nethercote, P.; Borman, P.; Chatfield, M.; Thompson, D.; Truman, K. The application of quality by design to analytical methods; Pharma. Tech, 2007, pp. 1-10.
[44]
Barmpalexis, P.; Kanaze, I.; Georgarakis, E. Developing and optimizing a validated isocratic reversed-phase high-performance liquid chromatography separation of nimodipine and impurities in tablets using experimental design methodology. J. Pharm. Biomed. Anal., 2009, 49, 1192-1202.
[45]
Janardhanan, S.; Manavalan, R.; Valliappan, K. Chemometric technique for the optimization of chromatographic system: Simultaneous HPLC determination of Rosuvastatin, Telmisartan, Ezetimibe and Atorvastatin used in combined cardiovascular therapy. Arab. J. Chem., 2016, 9(2), S1378-S1387.
[46]
Mahmoud, M.; Elkhoudarya, R.; Salamb, A.; Ghada, M. Hadadb. robustness testing in hplc analysis of clarithromycin, norfloxacin, doxycycline, tinidazole and omeprazole in pharmaceutical dosage forms using experimental design formulation. Curr. Pharm. Anal., 2014, 10, 58-70.
[47]
Prafulla, S.; Nageswara, R.; Teresa, C.; Suryakanta, S.; Chandra, P.; Jagadeesh, P. An overview of experimental designs in HPLC method development and validation. J. Pharm. Biomed. Anal., 2018, 147, 590-611.
[48]
Maria, P.; Alexander, S. Life cycle management of analytical methods. J. Pharm. Biomed. Anal., 2018, 147, 506-517.
[49]
ICH Guideline Q2 (R1): Validation of analytical procedures: Text and Methodology, 2005.
[50]
Osmar, R.; Antunes, J.; Emilli, A.; Rubiana, M.; Mainardes, K.; Najeh, K. Development and validation of HPLC-PDA method for the quantitative determination of diphenyl diselenide in poly(lactide) nanoparticles. Curr. Pharm. Anal., 2016, 12, 121-128.
[51]
Zar, H. Biostatistical analysis. 5th ed., London: Pearson Education [distributor], 2010.
[52]
Hadad, M.; Emara, S.; Mahmoud, M. Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms. Talanta, 2009, 79, 1360-1367.
[53]
Fedeniuk, W.; Ramamurthi, S.; McCurdy, R. Application of reversed-phase liquid chromatography and prepacked C18 cartridges for the analysis of oxytetracycline and related compounds. J. Chromatography B., 1996, 677, 291-297.
[54]
Patel, K.; Shah, P.; Shah, P.; Gandhi, T. Validated High-Performance Thin-Layer Chromatographic (HPTLC) method for simultaneous determination of nadifloxacin, mometasone furoate, and miconazole nitrate cream using fractional factorial design. J. Food Drug Anal., 2016, 24, 610-619.

Rights & Permissions Print Cite
Article Metrics
38
6
© 2024 Bentham Science Publishers | Privacy Policy